Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |